Immunizations

In this March 30, 2020, file photo, a man jogs past the Olympic rings in Tokyo.It’s been six months since the Tokyo Olympics were postponed until next year by the COVID-19 pandemic. Everyone from new Japan Prime Minister Yoshihide Suga to IOC President Thomas Bach have tried to assure the Japanese public and deep-pocketed sponsors that the Olympics will take place. (AP Photo/Jae C. Hong, File)
September 28, 2020 - 1:50 am
TOKYO (AP) — It's been six months since the Tokyo Olympics were postponed until next year by the COVID-19 pandemic. In the last few weeks, everyone from new Japan Prime Minister Yoshihide Suga to IOC President Thomas Bach have tried to assure the Japanese public and deep-pocketed sponsors that the...
Read More
FILE - In this April 1, 2020, file photo, Dr. Mark Ghaly, secretary of the California Health and Human Services, gestures to a chart showing the impact of the mandatory stay-at-home orders, during a news conference in Rancho Cordova, Calif. Dr. Ghaly urged state residents to renew their efforts to prevent spread of the coronavirus amid some troubling trends, Friday, Sept. 25, 2020. Ghaly said infection rates are rising in some areas and one state model projects hospitalizations, now at their lowest level since early April, could increase nearly 90% in the next month. (AP Photo/Rich Pedroncelli, Pool, File)
September 25, 2020 - 9:12 pm
SACRAMENTO, Calif. (AP) — California has begun to see concerning upticks in coronavirus data after a sustained period of decline, the state's top health official said Friday, urging people to renew efforts to prevent spread. The increases include the rate of cases per capita, hospital emergency...
Read More
People board a bus outside Waterloo station in London, Wednesday, Sept. 23, 2020, after Prime Minister Boris Johnson announced a range of new restrictions to combat the rise in coronavirus cases in England, Wednesday, Sept. 23, 2020. (Dominic Lipinski/PA via AP)
September 25, 2020 - 8:38 am
LONDON (AP) — U.S.-based Novavax has begun a late stage trial of its potential COVID-19 vaccine in the United Kingdom because the high-level of the coronavirus circulating in the country is likely to produce quick results, the pharmaceutical company said. Novavax plans to test the effectiveness of...
Read More
Zheng Zhongwei, an official with China's National Health Commission, holds a chart showing different priority groups for a coronavirus vaccine as he speaks during a press conference held to discuss COVID-19 vaccine-related issues at the State Council Information Office in Beijing, Friday, Sept. 25, 2020. A Chinese health official said Friday that the country's annual production capacity for COVID-19 vaccines will top 1-billion next year, following an aggressive government support program for new factories. (AP Photo/Mark Schiefelbein)
September 25, 2020 - 7:21 am
BEIJING (AP) — A Chinese health official said Friday that the country's annual production capacity for coronavirus vaccines will top 1 billion doses next year, following an aggressive government support program for construction of new factories. Capacity is expected to reach 610 million doses by...
Read More
FILE - In this Tuesday, March 3, 2020 file photo, Britain's Prime Minister Boris Johnson gestures, during a press conference at Downing Street on the government's coronavirus action plan in London. Britain botched its response to the coronavirus the first time around. Now many scientists fear it’s about to do it again. The virus is on the rise again in the U.K., which has recorded almost 42,000 COVID-19 deaths, with confirmed infections at their highest level since May. (AP Photo/Frank Augstein, Pool, File)
September 24, 2020 - 4:58 pm
GAITHERSBURG, Md. — A U.S. biotechnology company is moving its experimental COVID-19 vaccine into final-stage testing in Britain, a different kind of shot than other leading candidates. Novavax Inc. announced Thursday that the Phase 3 study getting underway in the United Kingdom aims to test up to...
Read More
FILE - In this Wednesday, Aug. 5, 2020 file photo, senior Clinical Research Nurse Ajithkumar Sukumaran prepares the COVID 19 vaccine to administer to a volunteer, at a clinic in London. The British government on Thursday, Sept. 24, 2020 says it may take part in a study that tries to deliberately infect volunteers who have been given an experimental vaccine against the coronavirus in an effort to more quickly determine if the vaccine works. The approach, called a challenge study, is risky but proponents think it may produce results faster than typical studies, which wait to see if volunteers who have been given an experimental treatment or a dummy version get sick. (AP Photo/Kirsty Wigglesworth, File)
September 24, 2020 - 4:37 pm
LONDON (AP) — The British government says it may take part in a study that tries to deliberately infect volunteers who have been given an experimental vaccine against the coronavirus in an effort to more quickly determine if the vaccine works. The approach, called a challenge study, is risky but...
Read More
Yin Weidong, CEO of the Chinese pharmaceutical company SinoVac, speaks to journalists during a tour of a vaccine factory in Beijing on Thursday, Sept. 24, 2020. SinoVac, one of China's pharmaceutical companies behind a leading COVID-19 vaccine candidate says its vaccine will be ready by early 2021 for distribution worldwide, including the U.S. (AP Photo/Ng Han Guan)
September 24, 2020 - 11:25 am
BEIJING (AP) — A Chinese pharmaceutical company said Thursday the coronavirus vaccine it is developing should be ready by early 2021 for distribution worldwide, including the United States. Yin Weidong, the CEO of SinoVac, vowed to apply to the U.S. Food and Drug Administration to sell CoronaVac in...
Read More
FILE - In this March 16, 2020, file photo, Neal Browning receives a shot at the Kaiser Permanente Washington Health Research Institute in Seattle, in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the coronavirus. Many world leaders at this week's virtual U.N. summit hope it will be a vaccine made available and affordable to all countries, rich and poor. But with the U.S., China and Russia opting out of a collaborative effort to develop and distribute a vaccine, and some rich nations striking deals with pharmaceutical companies to secure millions of potential doses, the U.N. pleas are plentiful but likely in vain. (AP Photo/Ted S. Warren, File)
September 24, 2020 - 9:38 am
JOHANNESBURG (AP) — If the United Nations was created from the ashes of World War II, what will be born from the global crisis of COVID-19? Many world leaders at this week’s virtual U.N. summit hope it will be a vaccine made available and affordable to all countries, rich and poor. But with the U.S...
Read More
FILE - In this Tuesday, May 13, 2014 file photo, AstraZeneca CEO Pascal Soriot leaves the British Parliament's Business Innovation and Skills Committee after a hearing in central London. Two firms developing COVID-19 vaccines say pharmaceutical companies are trying to give the public as much information as possible about their testing regimes as drugmakers and public health officials seek to boost confidence that any approved vaccine will be safe. AstraZeneca CEO Pascal Soriot and Paul Stoffels, chief scientific officer of Johnson & Johnson, said Thursday Sept. 24, 2020, that they recognize the coronavirus emergency demands increased transparency from vaccine developers to ensure the public has faith in the end product. (AP Photo/Lefteris Pitarakis, File)
September 24, 2020 - 7:32 am
LONDON (AP) — Two firms developing COVID-19 vaccines say pharmaceutical companies are trying to give the public as much information as possible about their testing regimes as drugmakers and public health officials seek to boost confidence that any approved vaccine will be safe. AstraZeneca CEO...
Read More
Tokyo Gov. Yuriko Koike, right, reacts before an on-line meeting focused on how to pull off the delayed Tokyo Games, in Tokyo, Thursday, Sept. 24, 2020. IOC President Thomas Bach delivered a pep talk to Japanese government officials and local organizers on Thursday that included suggestions that “hundreds of millions”of doses COVID-19 vaccines would be available before the postponed Olympic are to open on July 23, 2021. (Du Xiaoyi/Pool Photo via AP)
September 24, 2020 - 7:00 am
TOKYO (AP) — IOC President Thomas Bach delivered a pep talk to Japanese government officials and local organizers on Thursday that included suggestions that “hundreds of millions” of doses COVID-19 vaccines would be available before the postponed Olympics open in July. Bach was speaking from...
Read More

Pages